Epidemiological situation of rickettsioses in EU/EFTA countries
This report characterises the different reporting systems for tick-borne rickettsioses in EU/EFTA countries and identifies and assesses the current epidemiological situation of these diseases. It is the first attempt to collect existing data on rickettsioses in EU/EFTA countries.
This report is the first effort to collect existing data on rickettsioses in EU/EFTA countries covering the period 2000–2010. It characterises the different reporting systems for tick-borne rickettsioses in EU/EFTA countries and identifies and assesses the current epidemiological situation of these diseases, in order to better understand the magnitude of tick-borne rickettsiosis in the region.
Rickettsioses are bacterial infectious diseases that occur in endemic areas across large regions of the world. They require the presence of competent reservoir hosts, vectors and the pathogen. Rickettsioses surveillance is currently implemented in 14 countries of the EU/EEA using different case definitions. Yet data from human cases should not be the only source of information to determine risk areas for infection.
As tick-borne pathogens are listed among emerging communicable disease globally, they are expected to constitute an increasing burden to societies due to increasing travel, increasing cohorts of immunocompromised persons, and ageing societies
Tick-borne rickesstioses epidemiology in EU and EFTA countries
Most of the cases of rickettsioses are reported from Italy, Portugal and Spain. In the most affected countries rickettsioses commonly occurred among males. The age distribution of cases was variable with cases among persons younger than 9 years and older than 60 years in Portugal and the older age group more affected in Spain.
Surveillance of COVID-19 at long-term care facilities in the EU/EEA
19 May 2020 - The high COVID-19 morbidity and mortality observed among residents in long-term care facilities (LTCF) in EU/EEA countries poses a major challenge for disease prevention and control in such settings. Furthermore, the lack of special surveillance systems and the differences in testing strategies and capacities among countries may have led to a significant under-ascertainment and under-reporting of cases, contributing to a general underestimation of the disease burden and mortality in LTCFs.
Monitoring the responses to hepatitis B and C epidemics in the EU/EEA Member States, 2019
19 May 2020 - This report provides the first collation of data relating to the monitoring of the progress towards the elimination of hepatitis B and C for EU/EEA countries. This collated information represents an important step towards understanding the priority areas for action and gaps in the national responses to the hepatitis B and C epidemics. The data also provide an important baseline to help map progress towards the WHO elimination targets and ultimately achieve the 2030 sustainable development goals.
HIV Combination prevention: Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia (2018 progress report)
15 May 2020 - HIV combination prevention is an approach that brings together single prevention initiatives into a comprehensive programme. This approach considers that the offer of multiple evidence-based interventions in a comprehensive programme will have a greater impact on HIV transmission than investing in a single strategy. In this report we present and test the feasibility of a novel approach to monitoring the implementation of combination HIV prevention at national level.